Chula Vaccine Research Center (ChulaVRC) was invited to attend the Thailand Security Dial
From: Vaccine Insights Tuck Seng Wong, Kiat Ruxrungtham Vaccine security and self-relianc
The mRNA Technology Transfer Programme organized on 18 March 2024 in Singapore the 4th Sc
From: Department of Chemical and Biological Engineering, University of Sheffield Professo
Congratulations to Drew Weissman and Katalin Kariko for the Nobel Prize in Physiology or
From: The Independent Panel for Pandemic Preparedness and Response Statement of the Right
From BioNet-Asia ChulaCov19 BNA159 is a COVID–19 mRNA vaccine developed by Chulalong
เปิดรับสมัครอาสาสมัครสุขภาพดีสำหรับโครงการ ChulaCov19 BNA159 mRNA vaccine คุณสมบัติ อายุ
A COVID-19 vaccine made by BioNet-Asia in Ayutthaya, Thailand, should be cheaper than the
Dr.Chanchai Sittipunt, Dr.Nakorn Premsri, Dr.Suthipong Watcharasin and Dr.Kiat Ruxrungtham greetings to three Prince Mahidol Award 2021 laureates
Amid a global shortage of vaccines and a new wave of COVID-19 infections, some countries in Southeast Asia are rushing to develop their own coronavirus shots.
COVID19 Vaccine Tracker – Chulalongkorn University: ChulaCov19
The research team behind the development of a local mRNA Covid-19 vaccine on Monday asked the government to help finance the project
The Phase 1 trial of Thailand’s homegrown mRNA COVID-19 vaccine ChulaCOV-19, suggests the candidate vaccine can help the body elicit
The mRNA vaccine, currently being developed by the Vaccine Research Centre of the Faculty of Medicine of Chulalongkorn University, can stimulate the immune system to produce killer T-cells
The Faculty of Medicine at Bangkok’s Chulalongkorn University has put out a call for healthy volunteers to take part in trials of its Covid-19 mRNA vaccine.
TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human (FIH) phase 1 clinical trial in Thailand with mRNA
With Covid-19 battering Thailand and the third wave bringing the Sinovac-resistant Delta variant to the forefront of the pandemic,
